Clinical Trial Update: Trial in Adult Participants With Spinocerebellar Ataxia (SCA) [Phase 2, Phase 3]

View source ↗

Summary

A Biohaven-sponsored Phase 2/3 trial in adults with spinocerebellar ataxia has completed, and its results were posted in August 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia Type
• Spinocerebellar Ataxia Type 10

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-08-14